Influence of bovine lactoferrin on feeding intolerance and intestinal permeability in preterm infants: a randomized

Nermeen Ellakkany1,2, Hesham Abdel-Hady3, Ahmed Mahfouz Eita3

  • 1Faculty of Medicine, Horus University - Egypt, Damietta, Egypt. Nermeen.ellakany@gmail.com.

PubMed

Insights

Oral bovine lactoferrin (LF) supplementation improved feeding intolerance in preterm infants. This intervention also reduced intestinal permeability, as indicated by lower serum zonulin levels in the LF group.

Area of Science:

  • Neonatalogy
  • Gastroenterology
  • Immunology

Background:

  • Preterm infants (26-34 weeks gestational age) face feeding intolerance due to immature gastrointestinal function.
  • Bovine lactoferrin (LF) shows promise in managing feeding intolerance and sepsis.
  • This study investigates LF's impact on feeding intolerance and gut permeability in preterm neonates.

Purpose of the Study:

  • To assess the efficacy of oral bovine LF supplementation in preterm infants with feeding intolerance.
  • To evaluate the effect of LF on intestinal permeability using serum zonulin concentrations.

Main Methods:

  • A randomized controlled double-blind pilot study.
  • Sixty preterm neonates (26-34 weeks gestational age) with feeding intolerance were enrolled.
  • Participants were randomized to receive either bovine LF (100 mg/day) or a placebo for 4 weeks or until discharge.

Main Results:

  • The lactoferrin group achieved full enteral feeding significantly faster (9 vs. 15 days, P=0.001).
  • Serum zonulin concentrations were significantly lower in the lactoferrin group at study completion (3.38 vs. 5.49 ng/ml, P=0.04).

Conclusions:

  • Oral bovine lactoferrin improves feeding intolerance in preterm infants.
  • Bovine LF supplementation is associated with decreased intestinal permeability in this population.
Abstract